Canakinumab Bookmark Share View Topic Outline Subcut CanakinumabIlaris Mechanism of ActionA human monoclonal antibody that binds to IL-1β and inhibits its activity, resulting in reduced acute phase response.Clinical UseIndicationsAdverse Effects Want more info like this? MedSchool Your electronic clinical medicine handbook Guides to help pass your exams Tools every medical student needs Quick diagrams to have the answers, fast Quizzes to test your knowledge Sign Up Now